98 related articles for article (PubMed ID: 9475052)
1. In vitro cytotoxic effect of new diphenylphosphinoethane-copper(I) complexes on human ovarian carcinoma cells.
Adwankar MK; Wycliff C; Samuelson A
Indian J Exp Biol; 1997 Aug; 35(8):810-4. PubMed ID: 9475052
[TBL] [Abstract][Full Text] [Related]
2. Antitumor activity of new organometallic compounds in human ovarian cancer cell lines and comparison to platin derivatives.
Moebus VJ; Stein R; Kieback DG; Runnebaum IB; Sass G; Kreienberg R
Anticancer Res; 1997; 17(2A):815-21. PubMed ID: 9137413
[TBL] [Abstract][Full Text] [Related]
3. Targeting the folate receptor (FR): imaging and cytotoxicity of ReI conjugates in FR-overexpressing cancer cells.
Viola-Villegas N; Rabideau AE; Cesnavicious J; Zubieta J; Doyle RP
ChemMedChem; 2008 Sep; 3(9):1387-94. PubMed ID: 18651631
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic activity of some gold(III) complexes.
Cossu F; Matovic Z; Radanovic D; Ponticelli G
Farmaco; 1994 Apr; 49(4):301-2. PubMed ID: 8049012
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, characterization, and in vitro antitumor properties of tris(hydroxymethyl)phosphine copper(I) complexes containing the new bis(1,2,4-triazol-1-yl)acetate ligand.
Marzano C; Pellei M; Colavito D; Alidori S; Lobbia GG; Gandin V; Tisato F; Santini C
J Med Chem; 2006 Dec; 49(25):7317-24. PubMed ID: 17149861
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxicity of 2,2':6',2' '-terpyridineplatinum(II) complexes against human ovarian carcinoma.
Lowe G; Droz AS; Vilaivan T; Weaver GW; Park JJ; Pratt JM; Tweedale L; Kelland LR
J Med Chem; 1999 Aug; 42(16):3167-74. PubMed ID: 10447962
[TBL] [Abstract][Full Text] [Related]
7. Gold dithiocarbamate derivatives as potential antineoplastic agents: design, spectroscopic properties, and in vitro antitumor activity.
Ronconi L; Giovagnini L; Marzano C; Bettìo F; Graziani R; Pilloni G; Fregona D
Inorg Chem; 2005 Mar; 44(6):1867-81. PubMed ID: 15762713
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic activity of synthetic aza alkyl lysophospholipids against drug sensitive and drug resistant human tumor cell lines.
Morimoto H; Broquet C; Principe P; Mencia-Huerta JM; Braquet P; Bonavida B
Anticancer Res; 1991; 11(6):2223-9. PubMed ID: 1776863
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of cytotoxicity of copper(I) complexes of 1,2-bis(diphenylphosphino)ethane.
Sanghamitra NJ; Phatak P; Das S; Samuelson AG; Somasundaram K
J Med Chem; 2005 Feb; 48(4):977-85. PubMed ID: 15715467
[TBL] [Abstract][Full Text] [Related]
10. In vitro cytotoxicity of guanylhydrazones (MGBG and PGBG) on cultured Chinese hamster ovary cells.
Santa María A; Rodríguez C; San Andrés M; Sanz F; Ballesteros E
Methods Find Exp Clin Pharmacol; 1997 Oct; 19(8):521-5. PubMed ID: 9442474
[TBL] [Abstract][Full Text] [Related]
11. Antitumor activity of imidazothioxanthones in murine and human tumor models in vitro and in vivo.
Varvaresou A; Iakovou K; Gikas E; Fichtner I; Fiebig HH; Kelland LR; Double JA; Bibby MC; Hendriks HR
Anticancer Res; 2004; 24(2B):907-19. PubMed ID: 15161044
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic drug sensitivity testing of tumor cells from patients with ovarian carcinoma using the fluorometric microculture cytotoxicity assay (FMCA).
Csoka K; Larsson R; Tholander B; Gerdin E; de la Torre M; Nygren P
Gynecol Oncol; 1994 Aug; 54(2):163-70. PubMed ID: 7520407
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, cytotoxicity and antitumor activity of platinum(II) complexes of cyclopentanecarboxylic acid hydrazide.
Kushev D; Gorneva G; Taxirov S; Spassovska N; Grancharov K
Biol Chem; 1999 Nov; 380(11):1287-94. PubMed ID: 10614821
[TBL] [Abstract][Full Text] [Related]
14. New copper(I) phosphane complexes of dihydridobis(3-nitro-1,2,4-triazolyl)borate ligand showing cytotoxic activity.
Marzano C; Pellei M; Alidori S; Brossa A; Lobbia GG; Tisato F; Santini C
J Inorg Biochem; 2006 Feb; 100(2):299-304. PubMed ID: 16387362
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitous induction of resistance to platinum drugs in human ovarian, cervical, germ-cell and lung carcinoma tumor cells overexpressing isoforms 1 and 2 of dihydrodiol dehydrogenase.
Deng HB; Adikari M; Parekh HK; Simpkins H
Cancer Chemother Pharmacol; 2004 Oct; 54(4):301-7. PubMed ID: 15138708
[TBL] [Abstract][Full Text] [Related]
16. [Effects of anticancer agents on 7, 12-dimethylbenz (a) anthracene induced rat ovarian cancer cell line (DMBA-OC-1) and human ovarian serous adenocarcinoma cell line (KOC-1S)].
Kataoka A; Yokota D; Sugiyama T; Oda T; Nishida T; Yakushiji M
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Oct; 41(10):1523-9. PubMed ID: 2511256
[TBL] [Abstract][Full Text] [Related]
17. Correlation of drug response with the ATP tumorchemosensitivity assay in primary FIGO stage III ovarian cancer.
Konecny G; Crohns C; Pegram M; Felber M; Lude S; Kurbacher C; Cree IA; Hepp H; Untch M
Gynecol Oncol; 2000 May; 77(2):258-63. PubMed ID: 10785475
[TBL] [Abstract][Full Text] [Related]
18. Antitumor activity of a novel glyco-nitric oxide conjugate in ovarian carcinoma.
Cantuaria G; Magalhaes A; Angioli R; Mendez L; Mirhashemi R; Wang J; Wang P; Penalver M; Averette H; Braunschweiger P
Cancer; 2000 Jan; 88(2):381-8. PubMed ID: 10640972
[TBL] [Abstract][Full Text] [Related]
19. [Current results and perspectives of the use of human tumor cell lines for antitumor drug screening].
Zhukova OS; Dobrynin IaV
Vopr Onkol; 2001; 47(6):706-9. PubMed ID: 11826493
[TBL] [Abstract][Full Text] [Related]
20. Gene-specific repair of Pt/DNA lesions and induction of apoptosis by the oral platinum drug JM216 in three human ovarian carcinoma cell lines sensitive and resistant to cisplatin.
O'Neill CF; Koberle B; Masters JR; Kelland LR
Br J Cancer; 1999 Dec; 81(8):1294-303. PubMed ID: 10604725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
